Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest
- First Posted Date
- 2015-02-11
- Last Posted Date
- 2018-10-03
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 729
- Registration Number
- NCT02361216
- Locations
- 🇺🇸
Laser & Skin Surgery Center of Indiana, Carmel, Indiana, United States
A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
- Conditions
- Interventions
- First Posted Date
- 2015-02-04
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 16
- Registration Number
- NCT02355639
- Locations
- 🇩🇪
Charité - Universitaetsmedizin Berlin, Department of Dermatology and Allergy, Berlin, Germany
Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 219
- Registration Number
- NCT02310646
- Locations
- 🇨🇦
K.Papp Clinical Research Inc., Waterloo, Ontario, Canada
Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively
- First Posted Date
- 2014-12-03
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 189
- Registration Number
- NCT02305888
- Locations
- 🇺🇸
Long Island Skin Cancer and Dermatologic Surgery, Smithtown, New York, United States
Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
- First Posted Date
- 2014-08-19
- Last Posted Date
- 2016-06-14
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 30
- Registration Number
- NCT02219633
- Locations
- 🇩🇪
proinnovera GmbH, Center of Dermatology Excellence, Münster, Germany
LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2014-05-07
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 504
- Registration Number
- NCT02132936
- Locations
- 🇫🇷
Service de Dermatologie, Hôspital Larrey, Toulouse, France
LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2016-06-14
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT02126371
- Locations
- 🇬🇧
Covance CRU, Leeds, United Kingdom
Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions
- First Posted Date
- 2014-04-28
- Last Posted Date
- 2018-11-15
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 79
- Registration Number
- NCT02124239
- Locations
- 🇺🇸
Academic Dermatology Associate, Albuquerque, New Mexico, United States
Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
- First Posted Date
- 2014-04-22
- Last Posted Date
- 2019-01-04
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 224
- Registration Number
- NCT02120456
- Locations
- 🇺🇸
Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc., San Diego, California, United States
🇺🇸The Dermatology Group, P.C., Verona, New Jersey, United States
🇺🇸University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis
- Conditions
- Interventions
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2015-09-22
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 30
- Registration Number
- NCT02103725
- Locations
- 🇩🇪
bioskin GmbH, Hamburg, Germany